Yorvipath

Medicinal product

(Invented) name

Yorvipath

Active substance (s)

Palopegteriparatidas

Strength

294 µg/0,98 ml

Pharmaceutical form

injekcinis tirpalas užpildytame švirkštiklyje

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

H05AA05, palopegteriparatide

Marketing authorisation holder

Ascendis Pharma Bone Diseases A/S, Danija

Date of authorisation

2023-11-17

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection in pre-filled pen	0.98 ml
Palopegteriparatidas	294 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
112047	98162	1098162	užpildytas švirkštiklis	N2 ir 30 adatų (15, 18 ir 21 µg dozėms)		Receptinis	EU/1/23/1766/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-11-17	Registruotas